Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats
- PMID: 7756054
- DOI: 10.1016/8756-3282(94)00036-y
Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats
Abstract
The purpose of this study was to determine whether PTH has anabolic effects on cortical bone in aged ovariectomized (OVX) rats treated during the late stages of estrogen depletion. Groups of OVX rats were untreated for 1 year postovariectomy followed by treatment for 10 weeks with vehicle, estrogen, the bisphosphonate risedronate (NE-58095), calcitonin (CT), PTH, PTH + estrogen, PTH + NE-58095 or PTH+CT. A group of sham-operated control rats was treated with vehicle alone. Cross-sections of the tibial diaphysis immediately proximal to the tibiofibular junction were subjected to quantitative bone histomorphometry. In comparison to vehicle-treated control rats, the following structural changes were detected in cortical bone of vehicle-treated OVX rats: increased cortical bone tissue area, increased bone marrow area and a significant decrease in cortical width. Indices of endocortical bone formation were also significantly increased in vehicle-treated OVX rats relative to vehicle-treated control rats. Treatment with the antiresorptive agents estrogen, NE-58095 or CT prevented the decrease in cortical width in OVX rats, but failed to increase cortical bone area. In comparison to vehicle treatment of OVX rats, estrogen and CT decreased both periosteal and endocortical bone formation, whereas NE-58095 decreased endocortical, but not periosteal, bone formation. In contrast, treatment of OVX rats with PTH alone increased cortical bone area and width as well as decreased bone marrow area compared to vehicle treatment of OVX rats. The PTH-induced increase in cortical bone mass was associated with a marked increase in periosteal and endocortical bone formation. Concurrent treatment of OVX rats with PTH+estrogen, PTH + NE-58095 or PTH + CT did not have a greater anabolic effect on cortical bone than treatment with PTH alone. The results indicate that PTH, in contrast to estrogen, NE-58095 and CT, stimulates cortical bone formation and augments cortical bone mass in the tibial diaphysis of aged OVX rats. Therefore, cortical bone of aged OVX rats retains its ability to respond anabolically to PTH even during the late stages of estrogen depletion.
Similar articles
-
Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.Bone. 1995 Jun;16(6):629-35. doi: 10.1016/8756-3282(95)00115-t. Bone. 1995. PMID: 7669439
-
The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model.Bone. 1995 Feb;16(2):223-30. doi: 10.1016/8756-3282(94)00033-v. Bone. 1995. PMID: 7756051
-
Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats.Bone. 1994 Jan-Feb;15(1):51-8. doi: 10.1016/8756-3282(94)90891-5. Bone. 1994. PMID: 8024852
-
Present and future of osteoporosis therapy.Bone. 1995 Aug;17(2 Suppl):23S-29S. doi: 10.1016/8756-3282(95)00203-p. Bone. 1995. PMID: 8579894 Review.
-
Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis.Treat Endocrinol. 2002;1(3):175-90. doi: 10.2165/00024677-200201030-00005. Treat Endocrinol. 2002. PMID: 15799210 Review.
Cited by
-
Alendronate treatment promotes bone formation with a less anisotropic microstructure during intramembranous ossification in rats.J Bone Miner Metab. 2008;26(1):24-33. doi: 10.1007/s00774-007-0782-8. Epub 2008 Jan 10. J Bone Miner Metab. 2008. PMID: 18095060
-
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats.J Clin Invest. 2000 Jun;105(11):1595-604. doi: 10.1172/JCI9038. J Clin Invest. 2000. PMID: 10841518 Free PMC article.
-
Additive Effects of Mechanical Marrow Ablation and PTH Treatment on de Novo Bone Formation in Mature Adult Rats.Cells. 2012 Dec 5;1(4):1168-81. doi: 10.3390/cells1041168. Cells. 2012. PMID: 24710549 Free PMC article.
-
Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.Bone. 2014 Oct;67:257-68. doi: 10.1016/j.bone.2014.04.033. Epub 2014 Jul 10. Bone. 2014. PMID: 25016965 Free PMC article.
-
Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.J Clin Endocrinol Metab. 2010 Apr;95(4):1838-45. doi: 10.1210/jc.2009-1703. Epub 2010 Feb 17. J Clin Endocrinol Metab. 2010. PMID: 20164296 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical